Regeneron, Sanofi Asthma Therapy Dupixent Under FDA Review for Rare Skin Condition

Seeking Alpha37minutes ago

Live Stock News: Short Week with a Slow Start

Kevin Travers11:36 ET

Top Neuroscientist Matthew Anderson Appointed Co-Director of the Oxford-Harrington Rare Disease Centre

PR NewswireFeb 18 09:15 ET

Alvotech, Teva Pharmaceutical's Bionsimlar Eye Disorder Potential Treatment Accepted for FDA Review

MT NewswiresFeb 18 08:28 ET

SNY and REGN's Dupixent SBLA for Skin Disease Gets FDA's Priority Tag

Zacks Feb 18 07:01 ET

Regeneron, Sanofi Get Speedy FDA Review of Dupixent in Bullous Pemphigoid

WSJFeb 18 06:10 ET